Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>The software group focused on cybersecurity risk management announced its final audited results for the year ended 31 December 2025.</li>
<li>Revenue was £2.1m (2024: £2.1m), of which 86% was from subscriptions and 14% from consultancy services. £1.9m of contracted future revenue at the year end had risen to £2.1m at the end of Q1 2026 providing near-term revenue visibility.</li>
<li>The recently announced placing, directors’ subscription and retail offer provided £453,000 of additional funding for product development, sales &amp; marketing investment, and working capital.</li>
</ul>


The software group focused on cybersecurity risk management announced its final audited results for the year ended 31 December 2025.
Revenue was £2.1m (2024: £2.1m), of which 86% was from subscriptions and 14% from consultancy services. £1.9m of contracted future revenue at the year end had risen to £2.1m at the end of Q1 2026 providing near-term revenue visibility.
The recently announced placing, directors’ subscription and retail offer provided £453,000 of additional funding for product development, sales &amp; marketing investment, and working capital.


<ul>
<li>Anpario 520p £104.18m (ANP.L) The independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM today at which Matthew Robinson, Chairman, stated that the Company had a strong trading performance in the Middle-East, including the first sales of a new product, AmpLIPhy.</li>
<li>Growth has also continued at pace in the US across both the Bio-Vet and Anpario product ranges, as well as in Australasia.</li>
<li>Following the onset of recent disruptions, the Company initially absorbed increases in logistics costs for goods in transit, but ongoing higher costs have since largely been passed on to customers in accordance with the terms of trade. </li>
</ul>


Anpario 520p £104.18m (ANP.L) The independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM today at which Matthew Robinson, Chairman, stated that the Company had a strong trading performance in the Middle-East, including the first sales of a new product, AmpLIPhy.
Growth has also continued at pace in the US across both the Bio-Vet and Anpario product ranges, as well as in Australasia.
Following the onset of recent disruptions, the Company initially absorbed increases in logistics costs for goods in transit, but ongoing higher costs have since largely been passed on to customers in accordance with the terms of trade. 


Ajax Resources PLC - Hybridan Small Cap Feast: 18 June 2026

<ul>
<li>24th October: Sterling Digital, the bitcoin mining business, has announced its intention to seek admission on the Access segment of the Aquis Stock exchange.</li>
<li>The Company’s objective is to deliver sustainable long-term growth via compounding bitcoin exposure through cheapest-in-class mining and active management of bitcoin reserves.</li>
<li>The Company expects to raise money and Admission on or around 11 November 2025. </li>
</ul>


24th October: Sterling Digital, the bitcoin mining business, has announced its intention to seek admission on the Access segment of the Aquis Stock exchange.
The Company’s objective is to deliver sustainable long-term growth via compounding bitcoin exposure through cheapest-in-class mining and active management of bitcoin reserves.
The Company expects to raise money and Admission on or around 11 November 2025. 


Hybridan Small Cap Feast: 04 November 2025

<ul>
<li>The holding company for TIAA Limited, a specialist business assurance provider operating across the Housing, Healthcare, Government, Education, Charities, and other sectors, announced its consolidated final results and proposed dividend for the year ended 31 March 2025.</li>
<li>Total Revenue increased 7.7% to £10.0m (2024: £9.3m) and there was a 74% increase in profit before taxation to £0.8m (2024: £0.5m).</li>
<li>Cash balances were £1.1m as of 31 March 2025 (2024: £1.1m) with a proposed final dividend payment increase of 15.2% to 1.14 pence per share (2024: 0.99 pence) to be paid in September 2025.</li>
</ul>


The holding company for TIAA Limited, a specialist business assurance provider operating across the Housing, Healthcare, Government, Education, Charities, and other sectors, announced its consolidated final results and proposed dividend for the year ended 31 March 2025.
Total Revenue increased 7.7% to £10.0m (2024: £9.3m) and there was a 74% increase in profit before taxation to £0.8m (2024: £0.5m).
Cash balances were £1.1m as of 31 March 2025 (2024: £1.1m) with a proposed final dividend payment increase of 15.2% to 1.14 pence per share (2024: 0.99 pence) to be paid in September 2025.


<ul>
<li>The specialist in currency risk management and alternative banking, reports finals to December 2024.</li>
<li>Its revenue is £50.3m up from £49.9m, with growth in the number of clients offset by a reduction in average spend.</li>
<li>The EBITDA margin of 8% is ahead of previous expectations and operating loss of £0.2m compared to an operating profit of £8.1m. </li>
</ul>


The specialist in currency risk management and alternative banking, reports finals to December 2024.
Its revenue is £50.3m up from £49.9m, with growth in the number of clients offset by a reduction in average spend.
The EBITDA margin of 8% is ahead of previous expectations and operating loss of £0.2m compared to an operating profit of £8.1m. 


Surface Transforms PLC - Duplicate of Hybridan Small Cap Feast: 02/04/2025

United Kingdom

Genedrive is a molecular diagnostics company that develops and commercializes a rapid, versatile, and easy-to-use point-of-need molecular diagnostics platform. This platform is used for the diagnosis of infectious diseases, genotyping, and pathogen detection. Their key products include the Genedrive MT-RNR1 ID Kit for preventing antibiotic-induced hearing loss in neonates and the Genedrive CYP2C19 ID Kit for personalized antiplatelet treatment in stroke patients. The company is headquartered in Manchester, United Kingdom, and was founded in 2000.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Genedrive (GDR LN)

Hybridan Small Cap Feast: 29 June 2026

The recently announced placing, directors’ subscription and retail offer provided £453,000 of additional funding for product development, sales &...

Hybridan

Ajax Resources PLC - Hybridan Small Cap Feast: 18 June 2026

18th June 2026 @HybridanLLP Our daily digest of news from UK Small Caps * A corporate client of Hybridan...

Hybridan

Hybridan Small Cap Feast: 04 November 2025

24th October: Sterling Digital, the bitcoin mining business, has announced its intention to seek admission on the Access segment of the Aquis Stock...

Hybridan

Hybridan Small Cap Feast: 11/08/2025

The holding company for TIAA Limited, a specialist business assurance provider operating across the Housing, Healthcare, Government, Education,...

Hybridan

Surface Transforms PLC - Duplicate of Hybridan Small Cap Feast: 02/04/2025

The EBITDA margin of 8% is ahead of previous expectations and operating loss of £0.2m compared to an operating profit of £8.1m.

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)